The Globe and Mail quoted Steve Morgan, a health economist at UBC and advocate for national pharmacare, in an article about policies around the cost of expensive drugs.
“I think this idea of structuring pay-for-performance contracts and evaluating with greater rigour the real-world evidence that Canada could collect is prudent. It’s a good idea,” said
